Pan Cancer T B.V. Appoints Seasoned Entrepreneurs and Executives to its Supervisory Board and Elects its Chairman
. - John Tchelingerian, PhD (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board Pan…
. - John Tchelingerian, PhD (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board Pan…
. Amgen acquires all shares in Catherex Agreement consists of an upfront payment of USD 10.5 m, milestone payments and…
Virus-based biologics play an increasing role in the development of innovative gene, immuno and virotherapeutics. Novel…
Wissenschaftler im Deutschen Krebsforschungszentrum entdeckten, dass das Medikament Valproinsäure die Wirksamkeit von P…
Fresenius Kabi received a Warning Letter, dated July 1, from the U.S. Food and Drug Administration (FDA) related to an i…
Wissenschaftler aus dem Deutschen Krebsforschungszentrum entwickelten so genannte "RNA-Schalter", mit denen sie in Vire…
Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses,…
The biotech company MediGene AG (Frankfurt, Prime Standard, TecDAX) announces that MediGene, Inc., its wholly owned subs…